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 Summary
 Background: A challenge for clinicians in emergency departments (EDs) is rapid identification of those patients 
with chest pain who require admission and urgent management and those with low clinical risk 
who can be discharged safely from the ED. This study was designed with an aim to evaluate the 
ability of two-dimensional transthoracic echocardiography (2D-TTE) to determine causes of acute 
chest pain in patients presenting to the ED in order to decide whether hospital admission and 
further investigations were needed.
 Material/Methods: A total of 250 consecutive patients admitted with chest pain, were enrolled in this prospective 
study. Patients were divided into three groups: high risk, moderate risk, and low risk of cardiac 
events, according to cardiovascular risk factors. 2D-TTE was obtained using the HI vision Avius 
ultrasound unit (Hitachi). Statistical analysis was performed with the Statistical Package for the 
Social Sciences (SPSS), version 20.
 Results: Ischemic and/or non-ischemic heart diseases (IHD and/or NIHD) were detected in 147 (86.5%), 
13 (7.6%), and 10 (5.9%) patients with high, moderate, and low risk, respectively. 2D-TTE was 
characterized by sensitivity of 85.86%, specificity of 100%, and positive predictive value (PPV) of 
100% for detecting causes of chest pain.
 Conclusions: 2D-TTE increased specificity and sensitivity of detecting causes of chest pain, when compared 
to patient history, clinical findings, and electrocardiography (ECG). 2D-TTE can be used to help 
determine the need for hospital admission, to confirm or exclude diagnosis, and guide urgent 
therapy.
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Background
Chest pain is one of the most frequent reasons for patient 
visits in emergency departments (EDs). Possible causes 
of chest pain are numerous and diverse, but importantly, 
several conditions, such as acute coronary syndrome, pul-
monary embolism, and aortic dissection, require urgent 
management and, in some cases, may be life-threatening 
[1]. More than 8 million ED visits take place annually in 
the United States because of chest pain or related symp-
toms, which makes them the second most frequent cause 
of ED visits in adults [2]. A huge cost generated by patients 
with chest pain in the ED was recently confirmed in a 
retrospective study with 1000 patients, in which the mean 
cost per patient was almost €3,000 [3]. Therefore, a chal-
lenge for clinicians in EDs is rapid identification of those 
patients with chest pain who require urgent management 
and those with more benign entities who do not require 
admission [4,5]. To face this challenge, an increasing array 
of diagnostic strategies and modalities have been investi-
gated during the past decades, including chest pain units 
(CPUs), new cardiac biomarkers, clinical risk scores, early 
stress testing, accelerated diagnostic protocols (ADPs), 
and noninvasive imaging of the myocardium and coro-
nary arteries to provide a rapid and, cost-effective evalu-
ation [6].
Authors’ Contribution:
 A Study Design
 B Data Collection
 C Statistical Analysis
 D Data Interpretation
 E Manuscript Preparation
 F Literature Search
 G Funds Collection
Signature: © Pol J Radiol, 2017; 82: 798-805
DOI: 10.12659/PJR.904031
O R I G I N A L  A R T I C L E
798
2017.12.15
Two-dimensional transthoracic echocardiography (2D-TTE) 
is one of the most powerful diagnostic and monitoring tools 
available to critical care practitioners in EDs [7]. TTE is a 
safe, painless, and rapid diagnostic investigation that can 
be performed at bedside and contribute significantly to 
acute management of certain patients [8]. In addition, TTE 
can provide important information that can change man-
agement in 80% of patients, increase diagnostic accuracy 
and efficiency in EDs, and determine the cause of unex-
plained hypotension in 48% of intensive care units (ICUs). It 
can be used to monitor cardiac output, determine disorders 
of cardiac physiology, and provide anatomical information 
relevant to diagnosis [7].
Given its availability, rapidity, and additional information 
provided with regard to cardiac status, 2D-TTE may be 
used as the initial imaging modality when aortic dissection 
is clinically suspected in the emergency room. However, 
due to low negative predictive value (NPV), 2D-TTE does 
not permit to rule out dissection, and further tests will be 
required, if TTE is negative. The value of TTE is also lim-
ited in patients with abnormal chest wall configuration, 
obesity, pulmonary emphysema, and those on mechanical 
ventilation. These limitations may prevent adequate deci-
sion-making in some cases, but they can be overcome by 
transoesophageal echocardiography (TOE). In patients with 
acute chest pain, special attention should be paid during 
2D-TTE examinations to aortic root dilatation, aortic regur-
gitation, and/or pericardial effusion, since these findings 
should raise the suspicion of acute aortic syndrome. If dis-
section cannot be directly visualized, other imaging tech-
niques are mandatory [9].
Description of ischemic heart disease (IHD)
Acute myocardial infarction (AMI), occurs when part of the 
heart muscle is damaged by lack of blood flow. The most 
common symptom is chest pain or discomfort, which may 
radiate to the shoulder, arm, back, neck, or jaw [10]. A 
potential value of 2D echocardiography as a diagnostic tool 
in AMI was discovered very early, and a large number of 
studies reported its high sensitivity, both qualitatively and 
quantitatively. As a general rule, for the differentiation of 
normal from infarcted myocardium, wall thickening is pre-
ferred to wall motion. Moreover, 2D echocardiography is 
extremely accurate for localization of infarction. There is 
a significant relationship between infarction and contrac-
tile dysfunction; consequently, the absence of wall motion 
abnormality or wall thinning rules out a clinically signifi-
cant infarction [11].
Angina pectoris, commonly known as angina, is a sensa-
tion of chest pain, pressure, or squeezing that is often due 
to insufficient blood flow to the heart muscle because of 
obstruction or spasm of the coronary arteries [12]. Stable 
angina refers to the classic type of angina related to myo-
cardial ischemia. A typical presentation of stable angina 
is that of chest discomfort and associated symptoms pre-
cipitated by some activity (running, walking, etc.), with 
minimal or non-existent symptoms at rest or after admin-
istration of sublingual nitroglycerin. Unstable angina may 
occur unpredictably at rest, which may be a serious indi-
cator of an impending heart attack. What differentiates 
stable angina from unstable angina is the pathophysiology 
of atherosclerosis. Unstable angina results from a reduc-
tion of coronary blood flow due to transient platelet aggre-
gation on apparently normal endothelium, coronary artery 
spasms, or coronary thrombosis [13].
Description of non-ischemic heart disease (NIHD)
Hypertrophic cardiomyopathy (HCM) is a common, inher-
ited cardiovascular disease with an incidence of 1 in 500 
in the general population. It is caused by more than 1,400 
mutations in 11 or more genes encoding proteins of the 
cardiac sarcomere. Clinical diagnosis is based on other-
wise unexplained left-ventricular hypertrophy identified 
by echocardiography or cardiovascular magnetic resonance 
imaging (MRI) [14].
Restrictive cardiomyopathy is a specific group of heart 
muscle disorders characterized by inadequate ventricu-
lar relaxation during diastole. This leads to diastolic dys-
function with relative preservation of systolic function. 
Confirmation of diagnosis and information regarding the 
etiology, extent of myocardial damage, and response to 
treatment requires imaging. Echocardiography is the initial 
cardiac imaging technique, but it cannot reliably suggest a 
tissue diagnosis to differentiate restrictive cardiomyopathy 
from constrictive pericarditis. However, recent advances, 
such as tissue Doppler imaging and spectral tracking, have 
improved its ability to diagnose restrictive cardiomyopa-
thy [15].
Heart murmurs due to valvular abnormalities are common 
in the general population. Many heart murmurs have no 
clinical relevancy and are therefore called innocent mur-
murs [16]. Echocardiography is the imaging modality of 
choice to help diagnose and estimate the severity of aortic 
stenosis. 2D echocardiography demonstrates morphology 
of the aortic valve and can often delineate if it is trileaflet 
or bicuspid. It also aids in detecting other associated valve 
lesions and in estimating pulmonary artery systolic pres-
sure [17].
Pericardial effusion occurs in patients with pericarditic 
chest pain or in patients with underlying diseases that can 
cause pericardial involvement (renal failure, chest irra-
diation) and thoracic complaints. Echocardiography is the 
most available and reliable technique to verify the presence 
and the amount of pericardial effusion; in addition, echo-
cardiography offers valuable data for evaluation of hemo-
dynamic repercussion [18,19].
Classically, 2D-TTE has been considered to have a limit-
ed value for diagnosing aortic dissection. In older series, 
sensitivity of diagnosing ascending aorta dissection was 
78–90%, but only 31–55% in descending aortic dissection. 
Specificity for type A aortic dissection was reported to 
range from 87 to 96% and for type B dissection from 60 to 
83% [20]. However, these data are derived from old stud-
ies, when modern imaging technology, such as harmonic 
imaging, was not available. Recently, harmonic imaging 
and the use of contrast-enhanced imaging have been shown 
to improve sensitivity and specificity of 2D-TTE in diagnos-
ing aortic dissection [21]. Contrast-enhanced 2D-TTE has 
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similar accuracy to TOE in diagnosing type A aortic dissec-
tion (sensitivity, 93%; specificity, 97%), although it is lower 
in type B involvement (sensitivity, 84%; specificity, 94%), 
mainly in the presence of non-extended dissection, intra-
mural hematoma, and aortic ulcers [21].
The aim of the current study was to evaluate the ability of 
2D-TTE to determine the cause of acute chest pain and the 
hospitalization need in patients presenting to the ED.
Material and Methods
Between August 2014 and October 2016, a total of 250 con-
secutive patients admitted for chest pain, were enrolled 
in this prospective cohort study. All patients presented to 
the ED with chest pain or other symptoms suggestive of 
myocardial ischemia or infarction (MI) and underwent an 
evaluation by emergency physicians. The initial evaluation 
included patient history, physical examination, electrocar-
diography (ECG), and 2D-TTE. Patients with negative find-
ings were discharged and scheduled for follow-up stress 
testing within 24–48 hours, whereas those with positive 
findings were admitted. Additional diagnostic evaluations 
were made at the discretion of the cardiac care unit (CCU) 
cardiologist.
The CCU cardiologist evaluated admitted patients with 
regard to demographic data and, the following cardiovas-
cular risk factors: 1) family history, 2) high blood pressure 
(hypertension), 3) diabetes mellitus (DM), 4) smoking, 5) 
alcohol consumption, 6) unhealthy diet, 7) physical inac-
tivity, 8) obesity, 9) history of contraceptive pill use, and 
10) hormone replacement therapy (HRT). 2D-TTE findings, 
laboratory results, and exercise tests were also taken into 
account.
Also, it should be considered that patients who presented 
with chest pain were divided into three groups according 
to the above-mentioned risk factors: 1) patients at high 
risk; 2) moderate risk; and 3) low risk of cardiac events. 
High-risk patients were those with >3 cardiovascular risk 
factors, while moderate-risk patients were those with 3 
of the above-mentioned risk factors. Patients with a low 
risk had <3 of the listed risk factors. Informed consent was 
obtained from all patients, and the study was reviewed and 
approved by the institutional review board.
2D-TTE was obtained using the HI vision Avius ultrasound 
unit (Hitachi), immediately on arrival to the ED. The study 
was conducted by one expert sonologist, who was blinded 
to the patient’s status. An optimal phased array transducer 
with a frequency range of 1–5 MHz was used to perform 
scanning. 2D-TTE scanning included the apical four cham-
ber and two chamber views; para-sternal short and long 
axis, thoracic aorta, upper abdominal aorta, and inferior 
vena cava (IVC) were also visualized. Intra-cardiac shunt-
ing and valvular regurgitation were evaluated with color 
Doppler imaging. Motion mode (M-mode) was used to test 
the blood flow measures in cardiac chambers, cardiac 
valves, pulmonary veins, and thoracic aorta. Each 2D-TTE 
exam was recorded on a compact disc (CD) to be interpret-
ed later. In this research, 2D-TTE scanning guidelines and 
protocols were in line with Paventi et al., 2001 [22], and 
Levit and Jan, 2002 [23].
2D-TTE results were considered positive, when they docu-
mented IHD and/or NIHD (Figures 1 and 2). Sonographic 
features of abnormal wall movement, including akinesis 
or hypokinesis of one or more segments that presented in 
two different orientations, and a generalized hypokinesis 
Figure 1.  Parasternal short-axis view of the left ventricle (LV) at the level of the papillary muscles in a patient with an old inferior myocardial 
infarction (MI). The left panel was recorded at end-diastole and the right panel was recorded at end-systole. Thinning and lack of motion 
in the inferior wall can be noted (arrows).
Figure 2. Echocardiography in a 68-year-old male with HCM.
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with an ejection fraction lower than 40% were used to 
diagnose an ischemic cardiac event. The echocardiographic 
diagnostic criteria for HCM were established with M-mode 
imaging, and they included asymmetrical septal hypertro-
phy, systolic anterior motion (SAM) of the mitral valve, a 
small LV cavity, septal immobility, and premature closure 
of the aortic valve [24,25]. On 2D echocardiography, HCM 
is characterized by an increased left atrial diameter due to 
obstruction and/or diastolic dysfunction. Left atrial diam-
eter gives information on the risk of atrial fibrillation, 
heart failure development, and cardiac mortality, which is 
particularly high in patients with left atrial diameters >48 
mm. Finally, left atrial fractional shortening, determined 
with the following formula: ([maximal diameter-minimum 
diameter]/maximal diameter×100), is an estimate of end-
diastolic pressure in HCM. This parameter is directly relat-
ed to exercise tolerance, and its reduction (i.e. <16%) repre-
sents an independent risk factor for atrial fibrillation [26].
Normal ventricular size and systolic function are usually 
evident in restrictive cardiomyopathy. Findings that have 
been described as helpful in diagnosing restrictive cardio-
myopathy include mid-diastolic reversal of flow across the 
mitral and tricuspid valves. Atrial enlargement with nor-
mal left ventricular end-diastolic dimensions may also be 
seen [27]. As regards valvular abnormalities, aortic scle-
rosis on echocardiography is characterized by focal areas 
of valve thickening, typically located in the leaflet center 
with commissural sparing, and normal leaflet mobil-
ity. Diffuse leaflet thickening is not characteristic for aor-
tic sclerosis; instead, it suggests normal aging changes, a 
different valvular pathology, or an imaging artifact. With 
aortic sclerosis, valvular hemodynamics is within normal 
limits, with an aortic valve velocity of less than 2.5 m/s. 
In patients with aortic stenosis, the aortic valve is usu-
ally thickened and calcified, with limited excursion and a 
reduced aortic valve area. Doppler echocardiography is an 
excellent tool for evaluating the severity of aortic stenosis 
by measuring jet velocity and gradients and calculating the 
aortic valve area [28]. Pericardial effusion can be detected 
as an echo-free space on 2D echocardiography. Small col-
lections of pericardial fluid, which can be physiologic (25 
to 50 mL), may be visible during ventricular systole. When 
the amount of effusion is more than 50 mL, an echo-free 
space persists throughout the cardiac cycle. The next step 
is to assess the size of effusion, its location, hemodynamic 
importance, and associated diseases [29].
2D-TTE exams were deemed negative if segmental wall 
motion disorders and/or other non-ischemic events were 
absent. Clinical findings on physical examination, ECG, car-
diac computed tomography angiography (CTA), and cardiac 
MRI were used to verify whether echocardiographic diag-
noses of IHD and NIHD that were made in the ED were 
correct or not.
Study results were presented as means±standard devia-
tions (SD) in tables and figures. Statistical analysis was per-
formed with the Statistical Package for the Social Sciences 
(SPSS), version 20 for Windows (Microsoft).
Results
Between August 2014 and October 2016, a total of 250 con-
secutive patients with chest pain were admitted to the ED 
and enrolled in this study. Age ranged from 18 to 80 years 
(mean age, 67±2.4 years); there were 110 (44%) males and 
140 (56%) females (Table 1).
Patient demographic data and cardiovascular risk factors 
are presented in Table 1 and Figure 3. High blood pressure 
(150, 60%) and DM (128, 51.2%) were the most frequent 
causes of cardiovascular disorders in the patients. The least 
frequent causes of chest pain were a history of contracep-
tive pill use (18, 7.2%) and HRT (10, 4%) in females who had 
a history of breast and ovarian cancer (Table 1 and Figure 
3).
Demographic data (Years, n,%)
Age range 18 to 80 years
Mean age 67±2.4 years
Gender distribution 110 (44%) males and 140 (56%) females
Cardiovascular risk factors (n,%)
Family history of cardiac 
disorders (38, 15.2%)
High blood pressure 
(Hypertension) (150, 60%)
Diabetes mellitus (DM) (128, 51.2%)
Smoking (65, 26%)
Alcohol consumption (48, 19.2%)
Unhealthy diet (118, 47.2%)
Physical inactivity (93, 37.2%)
Obesity (55, 22%)
History of contraceptive pill 
use (18, 7.2%)
Hormone replacement therapy 
(HRT) (10, 4%)
Table 1.  Demographic data and cardiovascular risk factors in the 
studied patients.
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Figure 3.  Cardiovascular risk factors in patients presenting with chest 
pain.
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As regards the presence of cardiovascular risk factors, 
163 (65.2%) patients were at high risk of cardiovascular 
events, 26 (10.4%) and 61 (24.4%) patients were at moder-
ate and low risk, respectively. A family history of cardiac 
disorders (43, 26.7%), hypertension (122, 74.9%), DM (99, 
60.7%), smoking (52, 31.9%), unhealthy diet (69, 42.3%), and 
obesity (90, 55.2%) were common in high-risk patients. In 
patients at moderate risk, the frequency of cardiovascular 
risk factors as follows: family history of cardiac disorders 
(3, 11.5%), hypertension (23, 88.5%), and DM (20, 76.9%). 
In patients at low risk, the frequency of cardiovascular 
risk factors was as follows: smoking (18, 29.5%), alcohol 
consumption (3, 4.9%), unhealthy diet (12, 19.7%), obesity 
(7, 11.5%) history of contraceptive pill use (18, 29.5%), and 
HRT (10, 16.4%) (Figure 4).
All patients admitted to the ED with chest pain were 
screened for the presence of any associated clinical symp-
toms and signs (Figure 5). Clinical presentation of pressure, 
fullness, or tightness in the chest (200, 80%), and shortness 
of breath (183, 73.2%) were the commonest findings. Cold 
sweats (23, 9.2%) and nausea/vomiting (18, 7.2%) were least 
frequent. Shortness of breath (183, 73.2%) and dizziness or 
weakness (30, 12%) were also detected (Figure 5).
2D-TTE was conducted immediately on arrival to the ED. 
Out of 250 patients with chest pain who were enrolled in 
this study, 170 (68%) patients had positive 2D-TTE findings. 
Positive findings were detected in 147 (86.5%) patients in 
the high-risk group, in 13 (7.6%) patients in the moderate 
risk group, and in 10 (5.9%) patients in the low risk group.
The incidence of IHD was frequent in the high-risk group, 
as compared to the incidence of NIHD in the same group. 
Non-ischemic cardiac events were abundant in the remain-
ing two groups in comparison to ischemic disorders 
(Table 2).
The remaining patients with negative 2D-TTE findings (80, 
32%) were discharged and scheduled for follow-up stress 
testing within 24–48 hours; all were considered as high-
risk patients at the time of the initial evaluation. On fol-
low-up, stress testing revealed that only 28 (35%) had an 
AMI; ECG was abnormal and the average level of creatine 
kinase (CK) was 207 U/L.
As regards all risk groups, it was found that 2D-TTE had 
sensitivity of 85.86% (95% confidence interval (CI): 80.21% 
to 90.39%) and specificity of 100% (95% CI: 93.15% to 100%) 
for detecting IHD and NIHD. Furthermore, it had positive 
predictive value (PPV) of 100% (95% CI: 97.85% to 100%) 
and NPV of 65% (95% CI: 53.52% to 75.33%). In the current 
study, it was found that the prevalence of cardiac events 
was 79.2% (95% CI: 73.64% to 84.06%), with a negative like-
lihood ratio of 0.14 (95% CI: 0.10 to 0.20) (Table 3).
Discussion
Making correct diagnoses in patients presenting to the ED 
with chest pain is important to emergency physicians. To 
avoid discharging patients with AMI, most emergency phy-
sicians attempt to admit all patients in whom the possibil-
ity of acute coronary ischemia exists. These patients occu-
py expensive, intensive care beds, substantially increasing 
the financial cost of diagnosis and treatment of myocardial 
ischemia and AMI. Therefore, 2D-TTE, a rapid test, can 
provide very useful information on the cardiovascular sys-
tem. Additionally, the test can be easily performed at bed-
side. This makes it a very useful adjunct in evaluating ED 
patients with chest pain due to IHD and/or NIHD, resulting 
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Figure 4.  Distribution of cardiovascular risk factors in patients with high, moderate, and low risk of cardiac events.
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Figure 5. Clinical findings in patients presenting with chest pain.
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in lower morbidity and mortality rates [30]. Such 2D-TTE 
findings with respect to the incidence of IHD and NIHD 
in different patient groups are presented in Table 2. The 
patients were grouped according to the presence of cardio-
vascular risk factors (Figure 4).
The effect of real time 2D-TTE on medical decision mak-
ing in the ED was previously studied in 100 consecu-
tive patients presenting with suspected cardiac pathol-
ogy [23]. Echocardiography altered the diagnosis in 37% of 
patients, led to changes in treatment in 25% of patients, and 
increased physician confidence in their diagnosis in 50% 
ofcases [23]. In addition, the latest information available on 
Patient groups Incidence of IHD (n,%) Incidence NIHD (n,%) Total (n,%)
High risk group (125, 85%) (22, 15%) (147, 100%)
Moderate risk 
group (6, 46.2%) (7, 53.8%) (13, 100%)
Low risk group (2, 20%) (8, 80%) (10, 100%)
Patient groups Type of IHD (n,%) Type of NIHD (n,%) Total (n,%)
High risk group
Acute myocardial infarction (AMI) 
(33, 22.5%)
Hypertrophic cardiomyopathy (HCM) (12, 8.2%)
(147, 100%)
Restrictive cardiomyopathy (5, 3.4%)
Angina (stable/unstable) (92, 62.6%)
Valvular abnormalities (3, 2%)
Pericardial effusion (2, 1.3%)
Moderate risk 
group
Acute myocardial infarction (AMI) 
(2, 15.4%)
Hypertrophic cardiomyopathy (HCM) (3, 23%)
(13, 100%)
Restrictive cardiomyopathy (2, 15.4%)
Angina (stable/unstable) (4, 30.8%)
Valvular abnormalities (1, 7.7%)
Pericardial effusion (1, 7.7%)
Low risk group
Acute myocardial infarction (AMI) (1, 10%)
Hypertrophic cardiomyopathy (HCM) (1, 10%)
(10, 100%)
Restrictive cardiomyopathy (1, 10%)
Angina (stable/unstable) (1, 10%)
Valvular abnormalities (2, 20%)
Pericardial effusion (4, 40%)
Table 2. IHD and NIHD (by incidence and type) in different patient groups according to the number of risk factors.
Absence or presence of cardiac event in 2D-TTE Number of cases (n)
True positive 170
True negative 52
False positive 0
False negative 28
Performance of 2D-TTE in the evaluation of 
cardiac events Value 95% CI
Sensitivity (%) 85.86% 80.21% to 90.39%
Specificity (%) 100% 93.15% to 100%
Negative likelihood ratio 0.14 0.10 to 0.20
Cardiac events prevalence (%) 79.2% 73.64% to 84.06%
PPV (%) 100% 97.85% to 100%
NPV (%) 65% 53.52% to 75.33%
Table 3.  Performance of 2D-TTE in the evaluation of cardiac events in patients with chest pain.
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the performance of early echocardiography in the predic-
tion of cardiac events in ED patients with chest pain was 
as follows: sensitivity of 91% (95% CI: 79% to 97%), which 
was higher than that of ECG (40%; 95% CI: 27% to 55%; 
P<0.0001). Specificity of echocardiography was 75% (95% 
CI: 69% to 81%), which was significantly lower than that of 
ECG (94%; 95% CI: 90% to 97%; P<0.0001). PPVs were not 
significantly different (44%, 95% CI: 34% to 54%, and 60%, 
95% CI: 42% to 76%; P=0.12) [31]. In this study (Table 3), 
2D-TTE was characterized by sensitivity of 85.86% (95% CI: 
80.21% to 90.39%) and specificity of 100% (95% CI: 93.15% 
to 100%) for detection IHD and NIHD. Furthermore, 2D-TTE 
had PPV of 100% (95% CI: 97.85% to 100%) and NPV of 65% 
(95% CI: 53.52% to 75.33%). A low negative likelihood ratio 
of 0.14 (95% CI: 0.10 to 0.20) was also noted (Table 3).
Several recent studies that used 2D-TTE in EDs were 
focused on identifying only those patients who had AMI 
[32–34]. In contrast, the current study analyzed risk fac-
tors in different patient groups (Figure 4), and the onset of 
angina, either stable or unstable ones (Table 2). Focusing 
on MI exclusion alone may result in failure to identify 
patients with ongoing ischemia who have a significant 
risk of short- and long-term cardiovascular morbidity and 
mortality. Furthermore, early identification of patients 
with unstable angina may significantly reduce the risk of 
MI (Table 2). Also, as mentioned earlier in this study, 28 
(35%) out of 80 (32%) patients with negative 2D-TTE find-
ings had an AMI on echocardiography stress testing, where 
ECG was abnormal and the average level of CK was 207 
U/L. Such findings could be compared with the ability of 
stress echocardiography in distinguishing IHD from NIHD, 
as described by Duncan et al., 2003 [35]. They found that 
2D-TTE was a quantifiable, reproducible, and noninvasive 
technique for differentiating ischemic from non-ischemic 
cardiomyopathy with good sensitivity and specificity. In 
addition, Peteiro et al., 2003 [36] studied the role of exercise 
echocardiography in differentiating dilated cardiomyopa-
thy from ischemic left ventricular dysfunction. They found 
that global and/or regional left ventricular function impair-
ment with exercise is accurate for identifying patients with 
ischemic left ventricular dysfunction, which is in line with 
the current findings of 2D-TTE stress testing.
Among the limitations of the current study is that, as a 
part of the risk stratification process, not all patients were 
admitted, since low risk patients undergo early myocardi-
al perfusion imaging and are discharged home, if the study 
is negative. However, all admitted patients underwent an 
evaluation by emergency physicians. The initial evaluation 
included patient history, physical examination, ECG, and 
2D-TTE. Patients with negative findings were discharged 
and scheduled for follow-up stress echocardiography testing 
within 24–48 hours. Enrolment of consecutive patients who 
were grouped into three groups according to cardiovascular 
risk could be considered as one of the strengths of this study.
Conclusions
The results demonstrate that 2D-TTE was applied for 
determining a wide range of IHD and NIHD findings in 
patients at high, moderate, and low risk of cardiac events. 
It can be used to help determine the need for hospi-
tal admission, confirm or exclude specific diagnosis, and 
guide urgent therapy. 2D-TTE increased the specificity and 
sensitivity of diagnosis for the causes of chest pain, when 
compared to patient history, clinical symptoms and signs, 
and ECG findings. 2D-TTE stress testing is recommend-
ed, whenever there is a negative 2D-TTE finding among 
patients presenting to the ED with chest pain, because NPV 
of 2D-TTE is insufficient.
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